NEW YORK, July 6, 2022 /PRNewswire/ -- As per Zion Market Research study, the global hospital-acquired infection control market was valued at USD 28.99 billion in 2021. The global market is projected to grow to about USD 34.03 billion at a CAGR of 9.89% by 2028.
Key Industry Insights & Finding of the Hospital-Acquired Infection Control Market Reports:
- As per the analysis shared by our research analyst, the Hospital-Acquired Infection Control Market is expected to grow annually at a CAGR of around 9.89 % (2022-2028).
- Through the primary research, it was established that the Hospital-Acquired Infection Control Market was valued approximately USD 28.99 Billion in 2021 and is projected to reach to roughly USD 34.03 Billion by 2028.
- North America dominated the global hospital-acquired control market in 2021 with over 39% of the global market share.
- The same trend is expected in the future owing to excellent strategic decisions and collaborations between healthcare facilities and manufacturers to expand their user database.
- The rigorous initiatives by private companies to penetrate markets like Africa and the Middle East are expected to aid regional growth in the coming years.
- Asia-Pacific is expected to generate high CAGR in the coming years owing to an increased number of medical facilities thus propelling the use of HAI control methods, strict government regulations to maintain safety standards, and generally improving healthcare infrastructure.
Zion Market Research published the latest report titled as "Hospital-Acquired Infection Control Market By Infection Type (Bloodstream Infections, Hospital Acquired Pneumonia, Infections, Gastrointestinal Infections, Surgical Site, Urinary Tract Infections (UTIs), and Others), By Product & Service (Protective Barriers, Cleaning & Disinfection Products, Sterilization, and Endoscope Reprocessing Products), By End User (Ambulatory Surgical Centers, Hospitals & Clinics, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 - 2028," into their research database.
Hospital-Acquired Infection Control Market: Overview
Hospital-acquired infection (HAI) is a term used for infections that are acquired due to medical procedures or during medical care. The infections may occur in a rehabilitation facility, while receiving medical treatment for a wound, in an outpatient surgery center, hospital, or any other treatment facility. HAI occurs when bacteria or virus is able to enter a patient's body which generally happens through a wound or devices like a catheter. It may also occur due to the lungs' exposure to the bacteria.
HAI is widespread due to the presence of a variety of microorganisms like fungi, bacteria, viruses, or parasites and the infections can be of different types including ear infections, eye infections, sexually transmitted diseases, intestinal infections, lungs or respiratory disorders. HAI control refers to measures or ways of preventing the spread of such infections amongst patients.
The global hospital-acquired infection control market is a high revenue market because of various measures taken to detect HAI and develop strategies or methods to curb these infections given the threat hospital-acquired infections pose to a patient's safety.
Get a Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis): https://www.zionmarketresearch.com/sample/hospital-acquired-infection-control-market
Our Free Sample Report Includes:
- 2022 Updated Report Introduction, Overview, and In-depth industry analysis
- COVID-19 Pandemic Outbreak Impact Analysis Included
- 220 + Pages Research Report (Inclusion of Updated Research)
- Provide Chapter-wise guidance on Request
- 2022 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
- Includes Updated List of tables & figures
- Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
- Zion Market Research methodology
Industry Dynamics:
Hospital-Acquired Infection Control Market: Growth Drivers
- Increasing number of incisional procedures to propel market growth.
With advancements in technology, the healthcare sector has managed to grow exponentially in the last couple of years with the opening of multiple treatment facilities thus making healthcare accessible to a larger section of society. This in turn has propelled the number of surgical operations being carried out across the globe since the treatments have become more affordable owing to better reimbursement policies and government initiatives to upgrade the healthcare infrastructure of their country with the rising disposable income of the population in many regions. The increasing cases of incisional procedures leave the patients more vulnerable to HAS which in turn forces the healthcare authorities to have better control over the spread of such infections thus aiding the global hospital-acquired infection control market growth.
There is a significant increase in the geriatric population along with increasing medical cases of chronic diseases like cancer, respiratory disorders, heart problems, and others which assist in the global market expansion. These incidents are also coupled with the demand and need for upgrading the sterilization and disinfection process in medical facilities propelled by stringent rules laid down by governments to maintain safety standards in hospitals and clinics giving a positive push to the global market expansion.
Hospital-Acquired Infection Control Market: Restraints
- Safety concerns related to reusable medical equipment to restrain the market growth.
Many hospitals or medical facilities utilize reusable equipment for medical procedures since they are less expensive and create less wastage. However, if reusable equipment like an endoscope, stethoscope, etc. are not thoroughly sterilized post-use, the chances of spreading hospital-acquired infections become very high thus restraining the global market growth. This is due to the withholding of tissues, blood, and other body components on the equipment allowing microbial growth and resulting in the spread of HAIs.
Another reason for restraining the global hospital-acquired infection control market growth is the adverse effects of disinfectants and sterilizing solutions on patients' health.
Directly Purchase a Copy of the Report @ https://www.zionmarketresearch.com/buynow/su/hospital-acquired-infection-control-market
Hospital-Acquired Infection Control Market: Opportunities
- Growth in utilization of single-use equipment and introduction of ethylene oxide as a sterilizer to provide growth opportunities for market expansion.
Owing to the rising awareness about the utilization of single-use pieces of equipment along with an increasing number of manufacturers producing or investing in R&D of single-use equipment is expected to provide multiple growth opportunities in the global hospital-acquired infection control market.
Even though ethylene oxide is considered a carcinogenic agent and CDC has mentioned that prolonged exposure to ethylene oxide may lead to cancer, there has been a growth in exhaustive R&D for reintroducing ethylene oxide as a sterilizing agent for medical equipment since it is one of the most effective gaseous sterilization substance. Various modes and techniques to use the compound in medical equipment disinfection procedures are being researched, which is also propelled by the growth in the number of patients infected by Covid-19 and the adoption of large-scale sterilization procedures.
Hospital-Acquired Infection Control Market: Challenges
- Complexity of disinfecting advanced medical equipment to pose challenges in the market.
Due to technical advancement, there is a considerable change in the equipment technology as well as a rise in the number of extremely advanced medical tools like analyzers, endoscopes, and others. With this, comes the need for developing advanced sterilization procedures or products that can efficiently manage to disinfect such tools which may pose challenges in the global market expansion.
Global Hospital-Acquired Infection Control Market: Segmentation
- The global hospital-acquired infection control market is segmented based on infection type, products & services, end-user, and region.
By infection type, the global market is segmented into bloodstream infections, hospital-acquired pneumonia, infections, gastrointestinal infections, surgical site, UTIs, and others. The segment is expected to be dominated by urinary tract infections.
By product & services, the global market is segmented into protective barriers, cleaning & disinfection products, sterilization, and endoscope reprocessing products. The segment may be dominated by protective barriers since they dominated the market in 2020 and have been following the same trend.
By end-user, the global market segments are ambulatory surgical centers, hospitals & clinics, and others. The segment is expected to be led by ambulatory surgical centers with the highest CAGR during the forecast period.
Get More Insight before Buying@: https://www.zionmarketresearch.com/inquiry/hospital-acquired-infection-control-market
List of Key Players of Hospital-Acquired Infection Control Market:
- MMM Group
- 3M Company
- Fortive
- Matachana Group
- Steris Plc.
- Belimed AG
- Ecolab Inc
- Miele Group
- Sotera Health LLC
- Getinge AB
- Reckitt Benckiser
- Continental Equipment Company
- Pal International Contec Inc.
Key questions answered in this report:
- What are the growth rate forecast and market size for Hospital-Acquired Infection Control Market ?
- What are the key driving factors propelling the Hospital-Acquired Infection Control Market forward?
- What are the most important companies in the Hospital-Acquired Infection Control Market Industry?
- What segments does the Hospital-Acquired Infection Control Market cover?
- How can I receive a free copy of the Hospital-Acquired Infection Control Market sample report and company profiles?
Report Scope:
Report Attribute | Details |
Market size value in 2021 | USD 28.99 Billion |
Revenue forecast in 2028 | USD 34.03 Billion |
Growth Rate | CAGR of almost 9.89 % 2022-2028 |
Base Year | 2020 |
Historic Years | 2016 - 2021 |
Forecast Years | 2022 - 2028 |
Segments Covered | By Product Type, By Application, and By End Use |
Forecast Units | Value (USD Billion), and Volume (Units) |
Quantitative Units | Revenue in USD million/billion and CAGR from 2022 to 2028 |
Regions Covered | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World |
Countries Covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others |
Companies Covered | MMM Group, 3M Company, Fortive, Matachana Group, Steris Plc., Belimed AG, Ecolab Inc, Miele Group, Sotera Health LLC, Getinge AB, Reckitt Benckiser, Continental Equipment Company, and Pal International, Contec, Inc., C.B.M. S.r.l. Medical Equipment. |
Report Coverage | Market growth drivers, restraints, opportunities, Porter's five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis. |
Customization Scope | Avail customized purchase options to meet your exact research needs. https://www.zionmarketresearch.com/custom/7006 |
Free Brochure: https://www.zionmarketresearch.com/requestbrochure/hospital-acquired-infection-control-market
Recent Developments
- In September 2021, a partnership between Sodexo and Ecolab Inc. emerged for the prevention of HAIs. The partnership has resulted in a new program called Protecta Plus which assists hospitals and medical clinics in better prevention of hospital-acquired infections in the USA.
- In November 2021, the acquisition of Regulatory Compliance Associates (RCA) by Sotera Health Company has aided the expansion of quality, technical consulting, and regulatory capabilities in the USA.
Regional Dominance:
- North America to dominate the global market during the projection period.
North America dominated the global hospital-acquired control market in 2021 with over 39% of the global market share. The same trend is expected in the future owing to excellent strategic decisions and collaborations between healthcare facilities and manufacturers to expand their user database. The rigorous initiatives by private companies to penetrate markets like Africa and the Middle East are expected to aid regional growth in the coming years.
Asia-Pacific is expected to generate high CAGR in the coming years owing to an increased number of medical facilities thus propelling the use of HAI control methods, strict government regulations to maintain safety standards, and generally improving healthcare infrastructure. Asia Pacific Society of Infection Control is a non-government body aiding research on the prevention of the spread of HAIs.
Europe is expected to grow significantly because of the rising number of surgical medical cases and developed healthcare facilities.
Global Hospital-Acquired Infection Control Market is segmented as follows:
Hospital-Acquired Infection Control Market: By Infection Type Outlook (2022-2028)
- Bloodstream Infections
- Hospital-acquired Pneumonia
- Infections
- Gastrointestinal Infections
- Surgical Site
- UTIs
- Others
Hospital-Acquired Infection Control Market: By Products & Services Outlook (2022-2028)
- Protective Barriers
- Cleaning & Disinfection Products
- Sterilization
- Endoscope Reprocessing Products
Hospital-Acquired Infection Control Market: By End-User Outlook (2022-2028)
- Surgical Centers
- Hospitals & Clinics
- Others
Hospital-Acquired Infection Control Market: By Region Outlook (2022-2028)
North America
- The U.S.
- Canada
Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Press Release For Hospital-Acquired Infection Control Market : https://www.zionmarketresearch.com/news/global-hospital-acquired-infection-control-market
Browse Other Related Research Reports from Zion Market Research
- Healthcare E-Commerce Market - Global Industry Analysis: The global Healthcare E-Commerce Market accrued earnings worth approximately 353.1 (USD Billion) in 2020 and is predicted to gain revenue of about 840.1 (USD Billion) by 2028, is set to record a CAGR of nearly 17.1% over the period from 2021 to 2028.
- Quadriplegia Treatment Market - Global Industry Analysis: The global quadriplegia treatment market is projected to grow with a compound annual growth rate (CAGR) of approximately 4.2 percent during the forecast period.
- AI-based Clinical Trials Solution Provider Market - Global Industry Analysis: AI-based Clinical Trials Solution Provider Market accrued earnings worth approximately 1.32 (USD Billion) in 2020 and is predicted to gain revenue of about 5.53(USD Billion) by 2028, is set to record a CAGR of nearly 22.1% over the period from 2021 to 2028.
Browse through Zion Market Research's coverage of the Global Healthcare Industry
Follow Us on: LinkedIn | Twitter | Facebook
About Us
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us-after all-if you do well, a little of the light shines on us.
Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com/
Blog: https://zmrblog.com/
Logo: https://mma.prnewswire.com/media/1605489/Zion_Market_Research_Logo.jpg
